Your browser doesn't support javascript.
loading
A protocol for the development of core outcome sets for effectiveness trials and clinical audits in renal cell cancer (R-COS).
MacLennan, Steven; Wintner, Lisa M; Beyer, Katharina; Lawlor, Ailbhe; Tripathee, Sheela; Dabestani, Saeed; Marconi, Lorenzo; Giles, Rachel H; Woodward, Rose; Van Hemelrijck, Mieke; Bex, Axel; Zondervan, Patricia.
Afiliación
  • MacLennan S; Academic Urology Unit, Institute of Applied Health Sciences University of Aberdeen Aberdeen UK.
  • Wintner LM; University Hospital of Psychiatry II Medical University of Innsbruck Austria.
  • Beyer K; Translational Oncology and Urology Research (TOUR) King's College London London UK.
  • Lawlor A; Translational Oncology and Urology Research (TOUR) King's College London London UK.
  • Tripathee S; Academic Urology Unit, Institute of Applied Health Sciences University of Aberdeen Aberdeen UK.
  • Dabestani S; Department of Translational Medicine, Division of Urological Cancers Lund University Lund Sweden.
  • Marconi L; Department of Urology Kristianstad Central Hospital, Region Skane Kristianstad Sweden.
  • Giles RH; Department of Urology Coimbra University Hospital Coimbra Portugal.
  • Woodward R; International Kidney Cancer Coalition Duivendrecht The Netherlands.
  • Van Hemelrijck M; Action Kidney Cancer Charity Manchester UK.
  • Bex A; Translational Oncology and Urology Research (TOUR) King's College London London UK.
  • Zondervan P; Department of Urology Amsterdam University Medical Centers Amsterdam The Netherlands.
BJUI Compass ; 4(5): 504-512, 2023 Sep.
Article en En | MEDLINE | ID: mdl-37636213

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Idioma: En Revista: BJUI Compass Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Idioma: En Revista: BJUI Compass Año: 2023 Tipo del documento: Article